One of the only listed Medical College with hospital in listed Space in India , valuation is favorable still ,with little sense of humour , let's start✨ 🙏🧵 #kovai
1/n Greatest event that has taken place In the history of kovai medical College , inauguration of new medical College in coimbatore, with an intake of 150 MBBS students with affiliation of Tamilnadu DR.MGR Medical University- AR20
AT 23 ALMOST 4 BATCH COMPLETED.
2/n DNB course offered
✨Cardiology
✨General surgery
✨Critical care medicine
✨Internal medicine
✨Orthopedic
✨Paediatric
✨Urology
👉ICU COURSES
👉Fellow ship program
It's only intensive Care unit in South India,which has recognised by Fellow ship Program.
3/n Still lots of future scope in education sector like PG , Dental, Nursing, Ayush , Physiotherapy
4/n Department of radiotherapy added Asia's first hyper arc system thus allowing them to treat double the number of patients first time in this region & selected by the national board , New Delhi to start the country first Post doctoral program in interventional Radiology
5/n Kidney sharing ,3 donor donated to 3 recipient,kidney shared not to own relative,but to another pt whose immune factor match,again first feat to be performe in country considering the complexity of operating on six pt ,all pt are well ,leader in STEROIDS 🆓 transplant
6/n Dr.Thavamani Devi MBBS AB (USA) is main promoters of Company & she is actively
associated with growth of the Company since inception. Paediatrician having worked in
various Hospitals in USA for more than 20 yrs & gained valuable experience in Hospital Management.
7/n industry will witness convergence of human intelligence & artificial intelligence in delivering better
preventive & curative care. Artificial Intelligence (AI) will be one of the key tools to bridge the gap of specialists,
doctor & skilled healthcare workforce in India.
8/n started its commercial operation on June 1990, with a capacity of 200 Bed Hospital in the outskirts of Coimbatore.
Today it is grown as a 2000 approx bed multi-locational, multi-disciplinary Super specialty. BEST MULTI-SPECIALITY HOSPITAL IN SOUTH INDIA- ET2020🏥
10/n A picture with thousands words
11/n
Peripheral Centers
👉Kovai City Center, *Ramnagar, Coimbatore*
👉Kovai Sulur 🏥, *Sulur, Coimbatore*
👉Kovai Medical Center – *Erode*
👉Kovai Speciality🏥- *Erode*
👉Kovai*Kovilpalayam* 🏥
*KMCH TRAUMA CARE
12/n industry outlook
13/n
13/n ✨ARPOB ( AVG REV PER OPERATING BED)
✨ALOS ( AVG LENGTH OF STAY )
✨BED OCCUPANCY
✨BED CAPACITY
14/n kovai revenue 20,21,22 year
15/n Excellent net cash from operating activities 🫶👌💫
16/n Debt reduction is very good 😊 ,ab toh paise hi paise honge 😬
17/n Credit rating & other peers
18/n ✨One interesting point I want to poin that in 20,21 thier interest is 8.6% per annum but in 22 thier interest is 7.5 % per annum , loan at very competitive interest rate
✨Remuneration plus commission is high.
19/n Common sense lagao
20/n Excellent EPS growth with OPM sustainable
21/n ✨ Excellent purchase from open market
✨ Below 10000 only shareholders of company
22/n 👉Dividend every year only 3 RS , like MRF share holder kya karenge itni dhan rashi ka - bacchan Saab
👉RISK
One city concentration
Any other corporate hospital
Debt
Any capping on fees or charges by govt.
RTH Bill
Attrition rate of doctors
23/n 👉Valuation
Ev / Evita -9
Mkt cap 2000 cr =1854 bed approx one bed / one crore
PE -20
OPM- 25% vgud among the peer
Promoter-56%
Price 1990( 22/4/23)
If like this 🧵 credit to mentor ayush mittal sir ,
👉Source
AR.20,21,22
CREDIT RATING
SCREENER.
Equirus report
Valuepicker
24/n dropbox.com/s/biq09co3v98d…
Not sebi register invested and biased old investment & recently also purchase in last 7 days in family account 🧵 🔚🏥🙏
• • •
Missing some Tweet in this thread? You can try to
force a refresh
✨Frm 2003-13,it raised production to 7.1 bcpa,
expanded to overseas mkt & added marque client portfolio
2/n ✨2015-2018;
Was the period of big chill - falling oil threw public finance of commodity driven African market into tizzy and NCL growth froze ,margin collapse, demonetization / GST prevent India switch
#RPG#rpglife life science business analysis,
It's was my diwali pick trying make two cent to add some value
A turnaround company with margins expansion & get rid off from DPCO specially your monopoly product ✨🧵
1/n 👉Leader in immunosuppressant segment
👉50+ year rich legacy, integrated operation with capabilities of both development & mfg in API & formulation,
👉company operating in domestic & international mkts in branded formulation,
👉global generic, API🧬💊
2/n 👉6 text book brand are trusted by doctor and patient
👉3 mfg units
👉1100+ permanent employee
👉50+ countries presence,
👉Enduring relationship with leading generic players of World 🌍
Second wave of COVID 19 impacted lives ,bussiness across the board.
We have also started to see inflation across economic in the world, interest rate increase & with ukrarian war conflict,supply chain constraints.
2/n Even the world experienced chaos and disruption, we delivered our highest growth .
FY22 revenues grew by 58% to 183.84 crores while consolidated EBITDA grew by 72% to Rs 43.5 crore from 25.24 compared with the year ago period. EBITDA margins expanded to 23.6 % from 21.7%
3/n Net profit too increased by 112% to Rs 24.8crores from Rs 11.7 crores compared with the same period a year ago. #betadrugs commands a strong position in the Indian market with more than 112 SKUs and its products are available across all major Corporate & Govt hospitals.
Gufic bio science stock analysis
( RT if beneficial)
A Thread 🧵🧵👇
1/n Company analysis
Mkt cap 2280( 18/03/2022)
CMP 235
P/E 25
ROCE 29%
ROE -29%
PROMOTER HOLDING 65% TO 75%
DEBT TO EQUITY ALMOST NIL
2/n gufic is engaged in r&d, mfg, mkt,distribution & sale of pharma & allied products,3rd fastest growing among the 100 pharma in india,largest mfg of lyophilized injection in india & fully automated,therapy areas like antibiotic,antifungal,cardiac, infertilty,antiviral, ppi.